FGFR-IN-9 (Compound 19) is a potent, reversible and orally active FGFR inhibitor with an IC 50 of 17.1, 29.6, 30.7, 46.7 and 64.3 nM against FGFR4 WT , FGFR3, FGFR4 V550L , FGFR2 and FGFR1, respectively.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > FGFR
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.